Save up -80% on Pertuzumab

Note: this is a drug discount program, not an insurance plan.

RX BIN: 015558
RX PCN: HT
Group ID: DDN6600
Card Holder ID: DDN6600

Pharmacists and Patients support.

2018 Price of Perjeta

$9,673

2 vials 420mg/14ml

* price without discount in nearest pharmacy. Price may vary.

Claim your free Pertuzumab discount card

We offer free Pertuzumab coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Pertuzumab every time. What are you waiting for? Claim your prescription drug card now!

Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time

Pertuzumab volume of distribution

5.12 L

About RX24Drugs

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080

What is Pertuzumab

Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). It consists of two heavy chains and two lights chains that have 448 and 214 residues respectively. FDA approved June 8, 2012.

Pertuzumab mechanism of action

Pertuzumab is a humanized monoclonal antibody designed to bind to the HER2 receptor and inhibit the ability of HER2 to interact with other HER family members (HER1, HER2, HER3, and HER4) on the surface of cancer cells. The HER signaling pathway plays a role in the formation and growth of numerous cancers, and previous clinical trials of pertuzumab in a single agent setting had suggested clinical activity – including stable disease – in heavily pretreated patients with advanced ovarian and breast cancers.

Dosage forms of Pertuzumab

DrugDosageQuantityPrice
Perjeta14ml2 vials 420mg$9,934
Prescription Generics

false

International Brands

Perjeta

Synonyms

2C4 Antibody MOAB 2C4

Manufacturers

Hoffmann La Roche Limited

CAS number

380610-27-5

UNII

K16AIQ8CTM

State

solid

Affected organisms

Humans and other mammals

Indication of Pertuzumab

Pertuzumab is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

Toxicity of Pertuzumab

The most common adverse reactions ( 30%) with PERJETA in combination with trastuzumab and docetaxel were diarrhea, alopecia, neutropenia, nausea, fatigue, rash, and peripheral neuropathy.

RX24 Drugs Disclaimer: before buying a Pertuzumab on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Pertuzumab now!